Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C
Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C
复制标题
DOI:
10.1038/nm1122
复制
发表时间:
2004-12-01
期刊:
影响因子:
82.9
通讯作者:
Zlokovic, BV
中科院分区:
文献类型:
--
作者:
Liu, D;Cheng, T;Zlokovic, BV
Although thrombolytic effects of tissue plasminogen activator (tPA) are beneficial, its neurotoxicity(1-5) is problematic. Here, we report that tPA potentiates apoptosis in ischemic human brain endothelium and in mouse cortical neurons treated with N-methyl-D-aspartate (NMDA) by shifting the apoptotic pathways from caspase-9 to caspase-8, which directly activates caspase-3 without amplification through the Bid-mediated mitochondrial pathway(6). In vivo, tPA-induced cerebral ischemic injury in mice was reduced by intracerebroventricular administration of caspase-8 inhibitor, but not by caspase-9 inhibitor, in contrast to controls in which caspase-9 inhibitor, but not caspase-8 inhibitor, was protective. Activated protein C (APC), a serine protease with anticoagulant, anti-inflammatory and antiapoptotic activities(7), which is neuroprotective during transient ischemia(8,9) and promotes activation of antiapoptotic mechanisms in brain cells by acting directly on endothelium(9-11) and neurons(12), blocked tPA vascular and neuronal toxicities in vitro and in vivo. APC inhibited tPA-induced caspase-8 activation of caspase-3 in endothelium and caspase-3-dependent nuclear translocation of apoptosis-inducing factor in NMDA-treated neurons and reduced tPA-mediated cerebral ischemic injury in mice. Data suggest that tPA shifts the apoptotic signal in stressed brain cells from the intrinsic to the extrinsic pathway which requires caspase-8. APC blocks tPA's neurovascular toxicity and may add substantially to the effectiveness of tPA therapy for stroke.